Consequently, the combination of telomerase reverse transcriptase (TERT) promoter mutation, epidermal growth factor receptor (EGFR) amplification, and/or copy number changes (+7/−10) in isocitrate dehydrogenase (IDH)-wildtype diffuse astrocytomas defines glioblastoma, IDH-wildtype CNS WHO grade 4, even in cases that microscopically resemble a lower grade [4]. Here, EGFR is linked to diffuse astrocytoma.